Arnold & Porter LLP - Deborah L. Feinstein

Back to Biography Main »

Deborah L. Feinstein

Partner

Washington, DC

tel: +1 202.942.5015
fax: +1 202.942.5999

Deborah.Feinstein@ aporter.com

Download vCard

Practice Focus

Deborah Feinstein is a leading antitrust lawyer, principally focusing on merger and acquisition matters before the US Federal Trade Commission (FTC) and US Department of Justice (DOJ). She is named by National Law Journal as one of the 50 most influential women lawyers in America, Global Competition Review named her on its international list of the "Top 100 Women in Antitrust," and Super Lawyers named her one of the top 50 women lawyers in Washington, DC. Ms. Feinstein has advised clients on hundreds of transactions, involving virtually all sectors of the economy. She has particular experience in the following areas: retail, food, consumer products, healthcare, chemicals, automotive parts, and government contractors.

Representative Matters

Unilever in the sale of its Lawry's & Adolph's spice/seasonings business to McCormick.
Boston Scientific Corporation, the world's largest medical device company dedicated to less-invasive medicine, in its US$27 billion acquisition of Guidant. The transaction also included a US$4 billion pre-closing divestiture to Abbott Laboratories of Guidant's endovascular solutions and vascular intervention businesses but allowed Boston Scientific to retain rights with respect to Guidant's drug-eluting stent portfolio.
Loews Cineplex Entertainment Corporation in its merger with AMC Entertainment Inc. Together the firms will own or operate 334 theatres nationwide. The matter was resolved with the DOJ and various state attorneys general with the divestiture of only 10 theatres.
The Kroger Co. in its US$13.5 billion merger with Fred Meyer, Inc., negotiated with the FTC to require the divestiture of only 8 stores. The combined company became, at the time, the largest grocery retailer in the United States.
General Electric Corporation's US$2.1 billion acquisition of Instrumentarium OYJ, a manufacturer of high-technology medical equipment.
Philip Morris and Kraft in their US$18.9 billion acquisition of Nabisco Holdings Corporation, creating the world's largest food company. Negotiations with the FTC resulted in the divestiture of only minimal assets.
Occidental Chemical Company in the US$360 million purchase of Vulcan Materials Company's chemical assets.
PepsiCo in its US$14 billion acquisition of The Quaker Oats Company. The merger strengthened PepsiCo's food businesses and added Gatorade, the leading sports drink brand, to its portfolio.
Meritor Automotive in its merger with Arvin Industries to become ArvinMeritor, a leading automotive industry supplier.
NBC's US $5.2 billion acquisition of Vivendi Universal Entertainment, creating one of the world's largest media and entertainment companies.
Genzyme's acquisition of Novazyme. The acquisition combined the only two companies performing research and development on a rare disease.

Representative Matters

Unilever in the sale of its Lawry's & Adolph's spice/seasonings business to McCormick.
Boston Scientific Corporation, the world's largest medical device company dedicated to less-invasive medicine, in its US$27 billion acquisition of Guidant. The transaction also included a US$4 billion pre-closing divestiture to Abbott Laboratories of Guidant's endovascular solutions and vascular intervention businesses but allowed Boston Scientific to retain rights with respect to Guidant's drug-eluting stent portfolio.
Loews Cineplex Entertainment Corporation in its merger with AMC Entertainment Inc. Together the firms will own or operate 334 theatres nationwide. The matter was resolved with the DOJ and various state attorneys general with the divestiture of only 10 theatres.
The Kroger Co. in its US$13.5 billion merger with Fred Meyer, Inc., negotiated with the FTC to require the divestiture of only 8 stores. The combined company became, at the time, the largest grocery retailer in the United States.
General Electric Corporation' s US$2.1 billion acquisition of Instrumentarium OYJ, a manufacturer of high-technology medical equipment.
Philip Morris and Kraft in their US$18.9 billion acquisition of Nabisco Holdings Corporation, creating the world's largest food company. Negotiations with the FTC resulted in the divestiture of only minimal assets.
Occidental Chemical Company in the US$360 million purchase of Vulcan Materials Company's chemical assets.
PepsiCo in its US$14 billion acquisition of The Quaker Oats Company. The merger strengthened PepsiCo's food businesses and added Gatorade, the leading sports drink brand, to its portfolio.
Meritor Automotive in its merger with Arvin Industries to become ArvinMeritor, a leading automotive industry supplier.
NBC's US $5.2 billion acquisition of Vivendi Universal Entertainment, creating one of the world's largest media and entertainment companies.
Genzyme 's acquisition of Novazyme. The acquisition combined the only two companies performing research and development on a rare disease.

Rankings

The National Law Journal list of "Washington's Most Influential Women Lawyers" 2010

Chambers USA: America's Leading Lawyers for Business 2010 for Antitrust

The International Who's Who of Competition Lawyers 2010

Washington, DC Super Lawyers 2010: Named to the "Top 50 Women Lawyers in DC" list and ranked for Antitrust Litigation

Washingtonian's "Top Lawyers" 2009 for Antitrust

The Best Lawyers in America 2010 for Antitrust Law

Global Competition Review's "Women in Antitrust" 2009

Expert Guides “The Best of the Best USA 2009” for Competition and Antitrust

PLC Which lawyer? Yearbook 2009: Highly recommended for Competition/anti-trust

The National Law Journal list of "50 Most Influential Women Lawyers in America" 2007

Lawdragon 500 "Leading Lawyers in America" 2006

Global Competition Review's international list of "Top 100 Women in Antitrust" 2004

Articles

Deborah L. Feinstein and Jonathan Gleklen. "Country Q&A United States." (PDF: 412 kB) Practical Law Company's Cross-border Competition Handbook 2010: Volume 1.

William Baer and Deborah L. Feinstein. "Changing Emphasis: How Whole Foods Advances the FTC's Efforts to Transform Merger Litigation." (PDF: 66 kB) GPC: The Online Magazine for Global Competition Policy September 2008.

Deborah L. Feinstein and Michael B. Bernstein. "A Perspective on the Whole Foods Decision: Would the Most Important Evidence Please Stand Up?." Competition Policy International, Spring 2008.

Deborah L. Feinstein, Marleen Van Kerckhove and Barbara H. Wootton. "Merger remedies in the EU and US." (PDF: 193 kB) Practical Law Company's Cross-border Competition Handbook 2007/08: Volume 1.

Deborah L. Feinstein and Michael B. Bernstein. "All Over the Map: Grocery Store Enforcement from Von's to Whole Foods." (PDF: 131 kB) Antitrust, Fall 2007.

Deborah L. Feinstein. "Recent Trends in U.S. Merger Enforcement: Down But Not Out." (PDF: 117 kB) Antitrust, Summer 2007.

Douglas L. Wald and Deborah L. Feinstein. "Merger Enforcement in Innovation Markets: The Latest Chapter--Genzyme/Novazyme." (PDF: 80 kB) The Antitrust Source 20 Jul. (2004).

William Baer, Deborah L. Feinstein and Randal M. Shaheen. "Taking Stock: Recent Trends in U.S. Merger Enforcement." (PDF: 100 kB) Antitrust Spring 2004.

William Baer and Deborah L. Feinstein. "Fixing the Problem: Recent Developments in US Merger Remedies." Global Competition Review "The Antitrust Review of the Americas 2004".